Drugs Approved for Liver Cancer - National Cancer Institute

Drugs Approved for Liver Cancer - National Cancer Institute

Drugs Approved for Liver Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in liver cancer that are not listed here.

Drugs Approved for Liver Cancer

• Cabometyx (Cabozantinib-S-Malate)
• Cabozantinib-S-Malate
• Cyramza (Ramucirumab)
• Keytruda (Pembrolizumab)
• Lenvatinib Mesylate
• Lenvima (Lenvatinib Mesylate)
• Nexavar (Sorafenib Tosylate)
• Nivolumab
• Opdivo (Nivolumab)
• Pembrolizumab
• Ramucirumab
• Regorafenib
• Sorafenib Tosylate
• Stivarga (Regorafenib)

Related Resources

• Liver and Bile Duct Cancer—Patient Version
• Chemotherapy and You: Support for People With Cancer

• Updated: May 16, 2019